Combined antiretroviral and anti-tuberculosis drug resistance following incarceration

被引:0
|
作者
Stott, K. E. [1 ]
de Oliviera, T. [1 ,2 ]
Lessells, R. J. [1 ,3 ]
机构
[1] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa
[2] UCL, Res Dept Infect, London, England
[3] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England
基金
英国惠康基金;
关键词
SUB-SAHARAN AFRICA; SOUTH-AFRICA; HIV; TUBERCULOSIS; THERAPY; PRISON; INDIVIDUALS; INFECTION; MUTATIONS; CELL;
D O I
10.7196/SAJHIVMED.957
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We describe a case of HIV/tuberculosis (TB) co-infection from KwaZulu-Natal, South Africa, characterised by drug resistance in both pathogens. The development of drug resistance was linked temporally to two periods of incarceration. This highlights the urgent need for improved integration of HIV/TB control strategies within prison health systems and within the broader public health framework
引用
收藏
页码:135 / 137
页数:3
相关论文
共 50 条
  • [1] Safety implications of combined antiretroviral and anti-tuberculosis drugs
    Cerrone, Maddalena
    Bracchi, Margherita
    Wasserman, Sean
    Pozniak, Anton
    Meintjes, Graeme
    Cohen, Karen
    Wilkinson, Robert J.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (01) : 23 - 41
  • [2] Anti-tuberculosis drug resistance in Portugal
    Antunes, ML
    Aleixo-Dias, J
    Antunes, AF
    Pereira, MF
    Raymundo, E
    Rodrigues, MF
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (03) : 223 - 231
  • [3] National anti-tuberculosis drug resistance study in Tanzania
    Chonde, T. M.
    Basra, D.
    Mfinanga, S. G. M.
    Range, N.
    Lwilla, F.
    Shirima, R. P.
    van Deun, A.
    Zignol, M.
    Cobelens, F. G.
    Egwaga, S. M.
    van Leth, F.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (08) : 967 - 972
  • [4] Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India
    Swaminathan, S
    Paramasivan, CN
    Ponnuraja, C
    Iliayas, S
    Rajasekaran, S
    Narayanan, RR
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (08) : 896 - 900
  • [5] Anti-tuberculosis drug resistance in Dohuk, Iraq
    Merza, Muayad A.
    Farnia, Parissa
    Masjedi, Mohammad Reza
    Ridell, Malin
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (09) : 1213 - 1214
  • [6] Control of anti-tuberculosis drug resistance in Botswana
    Talbot, EA
    Kenyon, TA
    Mwasekaga, MJ
    Moeti, TL
    Mallon, V
    Binkin, NJ
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (01) : 72 - 77
  • [7] Primary drug resistance to anti-tuberculosis drugs in major towns of Amhara region, Ethiopia
    Yimer, Solomon Abebe
    Agonafir, Mulualem
    Derese, Yohannes
    Sani, Yusuf
    Bjune, Gunnar A.
    Holm-Hansen, Carol
    APMIS, 2012, 120 (06) : 503 - 509
  • [8] Anti-tuberculosis drug resistance in two clinics in Ecuador
    Mertz, BL
    Douce, RW
    Brito, N
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (02) : 115 - 117
  • [9] Anti-tuberculosis drug resistance and therapeutic dead end
    Veziris, Nicolas
    Robert, Jerome
    M S-MEDECINE SCIENCES, 2010, 26 (11): : 976 - 980
  • [10] Nationwide survey of anti-tuberculosis drug resistance in Japan
    Mitarai, Satoshi
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (02) : 157 - 162